Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10444)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G, Kumar AP. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? World J Gastroenterol 2015; 21(43): 12261-12273 [PMID: 26604635 DOI: 10.3748/wjg.v21.i43.12261] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12261.htm |
| Number | Citing Articles |
| 1 |
Chin-Yap Loh, Jian Chai, Ting Tang, Won Wong, Gautam Sethi, Muthu Shanmugam, Pei Chong, Chung Looi. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells 2019; 8(10): 1118 doi: 10.3390/cells8101118
|
| 2 |
Ya-kai Huang, Wei-ming Kang, Zhi-qiang Ma, Yu-qin Liu, Li Zhou, Jian-chun Yu. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Carcinogenesis 2019; 40(2): 370 doi: 10.1093/carcin/bgy142
|
| 3 |
Francesca Battaglin, Giovanni Randon, Alessandra Raimondi, Filippo Pagani, Hiroyuki Arai, Filippo Pietrantonio, Heinz-Josef Lenz. Molecular Determinants of Gastrointestinal Cancers. Advances in Oncology 2021; 1: 311 doi: 10.1016/j.yao.2021.02.026
|
| 4 |
Zhiyuan Wang, Zijin Shen, Haibin Wang, Lin Zhang, Rong Dong. Effect of dexmedetomidine on the cognitive function of patients undergoing gastric cancer surgery by regulating the PI3K/AKT signaling pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.11224
|
| 5 |
Wei Liu, Meijin Li. The role of claudin-4 in the development of gastric cancer. Scandinavian Journal of Gastroenterology 2020; 55(9): 1072 doi: 10.1080/00365521.2020.1795923
|
| 6 |
Runze Xu, Ran Xu, Yuanxiang Wang, Weixing Wang, Lingling Jiang, Shishun Gong, Osamah Ibrahim Khalaf. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6881932
|
| 7 |
Diana-Theodora Morgos, Constantin Stefani, Daniela Miricescu, Maria Greabu, Silviu Stanciu, Silvia Nica, Iulia-Ioana Stanescu-Spinu, Daniela Gabriela Balan, Andra-Elena Balcangiu-Stroescu, Elena-Claudia Coculescu, Dragos-Eugen Georgescu, Remus Iulian Nica. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer. International Journal of Molecular Sciences 2024; 25(3): 1848 doi: 10.3390/ijms25031848
|
| 8 |
Jong Hyun Lee, Chulwon Kim, Seok-Geun Lee, Woong Mo Yang, Jae-Young Um, Gautam Sethi, Kwang Seok Ahn. Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells. Phytomedicine 2018; 40: 165 doi: 10.1016/j.phymed.2018.01.002
|
| 9 |
Syedeh Elham Norollahi, Fariborz Mansour-Ghanaei, Farahnaz Joukar, Shervin Ghadarjani, Kourosh Mojtahedi, Kaveh Gharaei Nejad, Hossein Hemmati, Faeze Gharibpoor, Roya Khaksar, Ali Akbar Samadani. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomedicine & Pharmacotherapy 2019; 115: 108958 doi: 10.1016/j.biopha.2019.108958
|
| 10 |
Hiroo Imai, Ken Saijo, Sonoko Chikamatsu, Yoshifumi Kawamura, Chikashi Ishioka. LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK‐A11. Cancer Science 2021; 112(2): 792 doi: 10.1111/cas.14759
|
| 11 |
Ying Luo, Dan Zhang, Leping Hou, Nengming Lin. Vernodalin Suppresses Tumor Proliferation and Increases Apoptosis of
Gastric Cancer Cells Through Attenuation of FAK/PI3K/AKT/mTOR and
MAPKs Signaling Pathways. Current Pharmaceutical Biotechnology 2023; 24(5): 708 doi: 10.2174/1389201023666220728150544
|
| 12 |
Dongmei Fan, Baoqi Ren, Xiaojun Yang, Jia Liu, Zhengzheng Zhang. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0432-x
|
| 13 |
Nand Kishor Roy, Javadi Monisha, Ganesan Padmavathi, H. Lalhruaitluanga, Nachimuthu Senthil Kumar, Anuj Kumar Singh, Devivasha Bordoloi, Munindra Narayan Baruah, Gazi Naseem Ahmed, Imliwati Longkumar, Frank Arfuso, Alan Prem Kumar, Ajaikumar B. Kunnumakkara. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. Biomolecules 2019; 9(7): 253 doi: 10.3390/biom9070253
|
| 14 |
Ali Dehshahri, Milad Ashrafizadeh, Elham Ghasemipour Afshar, Abbas Pardakhty, Ali Mandegary, Reza Mohammadinejad, Gautam Sethi. Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems. Pharmacological Research 2020; 151: 104551 doi: 10.1016/j.phrs.2019.104551
|
| 15 |
Zhiguo Zhang, Yutong Sui, Liyi Luan, Bo Li, Chuan Qin. Retracted: A Novel CircRNA Circ_0095424 Regulates Proliferation, Metastasis, and Apoptosis of Osteosarcoma Cells Via the PI3K/AKT Signaling Pathway Through Targeting the miR-1238/HMGB1 Axis. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(10): e802 doi: 10.1089/cbr.2020.3563
|
| 16 |
Denisa Leonte, Daniel Ungureanu, Valentin Zaharia. Flavones and Related Compounds: Synthesis and Biological Activity. Molecules 2023; 28(18): 6528 doi: 10.3390/molecules28186528
|
| 17 |
Hui Cai, Changqing Jing, Xusheng Chang, Dan Ding, Ting Han, Junchi Yang, Zhengmao Lu, Xuguang Hu, Zhaorui Liu, Jinshen Wang, Liang Shang, Shouxin Wu, Peng Meng, Ling Lin, Jiangman Zhao, Mingming Nie, Kai Yin. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1941-0
|
| 18 |
Yue-Chao Qin, Xin Yan, Xiao-Lin Yuan, Wei-Wei Yu, Fan-Jie Qu. Osteopontin promotes gastric cancer progression <i>via</i> phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. World Journal of Gastrointestinal Oncology 2023; 15(9): 1544-1555 doi: 10.4251/wjgo.v15.i9.1544
Abstract(390) |
Core Tip(473) |
Full Article(HTML)(1063)
|
Full Article with Cover (PDF)-3603K(58)
|
Full Article (Word)-1782K(25)
|
Audio-940K(9)
|
Peer-Review Report-227K(45)
|
Answering Reviewers-206K(45)
|
Full Article (PDF)-3310K(86)
|
Full Article (XML)-127K(41)
|
Times Cited (2)
|
Total Visits (4294)
|
Open
|
| 19 |
Xiaoxiao Li, Zirui Tang, Zhaopeng Li, Zhao Li, Ping Zhao, Yi Song, Kexin Yang, Zihan Xia, Yinan Wang, Dong Guo. Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma. Pathology - Research and Practice 2024; 257: 155310 doi: 10.1016/j.prp.2024.155310
|
| 20 |
Qiang Wu, Xuewei Yi. Down-regulation of Long Noncoding RNA MALAT1 Protects Hippocampal Neurons Against Excessive Autophagy and Apoptosis via the PI3K/Akt Signaling Pathway in Rats with Epilepsy. Journal of Molecular Neuroscience 2018; 65(2): 234 doi: 10.1007/s12031-018-1093-3
|
| 21 |
Milad Ashrafizadeh, Zahra Ahmadi, Niranjan G. Kotla, Elham Ghasemipour Afshar, Saeed Samarghandian, Ali Mandegary, Abbas Pardakhty, Reza Mohammadinejad, Gautam Sethi. Nanoparticles Targeting STATs in Cancer Therapy. Cells 2019; 8(10): 1158 doi: 10.3390/cells8101158
|
| 22 |
Choudhary Harsha, Kishore Banik, Hui Li Ang, Sosmitha Girisa, Rajesh Vikkurthi, Dey Parama, Varsha Rana, Bano Shabnam, Elina Khatoon, Alan Prem Kumar, Ajaikumar B. Kunnumakkara. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. International Journal of Molecular Sciences 2020; 21(9): 3285 doi: 10.3390/ijms21093285
|
| 23 |
Atoosa Keshavarzmotamed, Vahide Mousavi, Niloufar Masihipour, Atefe Rahmati, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Mina Alimohammadi, Alireza Mafi. Regulating miRNAs Expression by Resveratrol: Novel Insights based on
Molecular Mechanism and Strategies for Cancer Therapy. Current Molecular Pharmacology 2023; 17 doi: 10.2174/0118761429249717230920113227
|
| 24 |
Qian Chen, Lang Hu, Kaihua Chen. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.570325
|
| 25 |
Lenka Varinská, Lenka Fáber, Martin Kello, Eva Petrovová, Ľudmila Balážová, Peter Solár, Matúš Čoma, Peter Urdzík, Ján Mojžiš, Emil Švajdlenka, Pavel Mučaji, Peter Gál. β-Escin Effectively Modulates HUVECs Proliferation and Tube Formation. Molecules 2018; 23(1): 197 doi: 10.3390/molecules23010197
|
| 26 |
Vaishnavi U. Warrier, Amina I. Makandar, Manoj Garg, Gautam Sethi, Ravi Kant, Jayanta K. Pal, Eiji Yuba, Rajesh Kumar Gupta. Engineering anti-cancer nanovaccine based on antigen cross-presentation. Bioscience Reports 2019; 39(10) doi: 10.1042/BSR20193220
|
| 27 |
Kishore Banik, Abhishek Manoj Ranaware, Choudhary Harsha, Thakur Nitesh, Sosmitha Girisa, Vishwas Deshpande, Lu Fan, Savita Pravin Nalawade, Gautam Sethi, Ajaikumar B. Kunnumakkara. Piceatannol: A natural stilbene for the prevention and treatment of cancer. Pharmacological Research 2020; 153: 104635 doi: 10.1016/j.phrs.2020.104635
|
| 28 |
Jialin Li, Bo Diao, Sheng Guo, Xiaoyong Huang, Chengying Yang, Zeqing Feng, Weiming Yan, Qin Ning, Lixin Zheng, Yongwen Chen, Yuzhang Wu. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nature Communications 2017; 8(1) doi: 10.1038/s41467-017-01327-4
|
| 29 |
Sadegh Fattahi, Fatemeh Amjadi-Moheb, Reza Tabaripour, Gholam Hossein Ashrafi, Haleh Akhavan-Niaki. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sciences 2020; 262: 118513 doi: 10.1016/j.lfs.2020.118513
|
| 30 |
Shanshan Luo, Rujing Lin, Xiwen Liao, Daimou Li, Yuzhou Qin. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03086-1
|
| 31 |
Fatemeh Ghafari, Ali Mohammad Alizadeh, Shahram Agah, Shiva Irani, Marjan Mokhtare. Serum Level of Insulin-Like Growth Factor 1 and its Relation to <i>Helicobacter Pylori</i> in Different Stages of Gastric Cancer. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3996125
|
| 32 |
Jinlan Shan, Zhen Wang, Qiuping Mo, Jingpei Long, Yangfan Fan, Lu Cheng, Tao Zhang, Xiyong Liu, Xiaochen Wang. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway. Pancreatology 2022; 22(3): 401 doi: 10.1016/j.pan.2022.03.002
|
| 33 |
Xiaofen Zhou, Erjie Xia, Adheesh Bhandari, Chen Zheng, Jingjing Xiang, Yaoyao Guan, Xiaohua Zhang. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer. Biochemical and Biophysical Research Communications 2018; 503(1): 257 doi: 10.1016/j.bbrc.2018.06.012
|
| 34 |
Bo Sun, Haiyuan Sun, Qunying Wang, Xinhong Wang, Jingzi Quan, Dongfang Dong, Yue Lun. Circular RNA circMAN2B2 promotes growth and migration of gastric cancer cells by down‐regulation of miR‐145. Journal of Clinical Laboratory Analysis 2020; 34(6) doi: 10.1002/jcla.23215
|
| 35 |
Che Zhang, Guangzhao Pan, Jiang-Jiang Qin. Role of F-box proteins in human upper gastrointestinal tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(1): 189035 doi: 10.1016/j.bbcan.2023.189035
|
| 36 |
Moussa Ide Nasser, Muqaddas Masood, Wei Wei, Xiaochun Li, Yifa Zhou, Bao Liu, Jiang Li, Xiaomeng Li. Cordycepin induces apoptosis in SGC-7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS. International Journal of Oncology 2017; 50(3): 911 doi: 10.3892/ijo.2017.3862
|
| 37 |
Jiaxin Xu, Yunhe Chen, Rui Yang, Tong Zhou, Wei Ke, Yuan Si, Shusheng Yang, Te Zhang, Xuewen Liu, Liang Zhang, Ke Xiang, Yang Guo, Ying Liu. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity. Archives of Biochemistry and Biophysics 2020; 684: 108314 doi: 10.1016/j.abb.2020.108314
|
| 38 |
Milad Ashrafizadeh, Hui Li Ang, Ebrahim Rahmani Moghadam, Shima Mohammadi, Vahideh Zarrin, Kiavash Hushmandi, Saeed Samarghandian, Ali Zarrabi, Masoud Najafi, Reza Mohammadinejad, Alan Prem Kumar. MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 2020; 10(7): 1040 doi: 10.3390/biom10071040
|
| 39 |
Devivasha Bordoloi, Kishore Banik, Ganesan Padmavathi, Rajesh Vikkurthi, Choudhary Harsha, Nand Kishor Roy, Anuj Kumar Singh, Javadi Monisha, Hong Wang, Alan Prem Kumar, Ajaikumar B Kunnumakkara. TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade. Biomolecules 2019; 9(12): 836 doi: 10.3390/biom9120836
|
| 40 |
Xiong Shu, Pan-Pan Zhan, Li-Xin Sun, Long Yu, Jun Liu, Li-Chao Sun, Zhi-Hua Yang, Yu-Liang Ran, Yue-Min Sun. BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.659260
|
| 41 |
Juan Chen, Jingdong Kang, Shouli Yuan, Peter O’Connell, Zizhu Zhang, Lina Wang, Junying Liu, Rongfeng Chen. Exploring the Mechanisms of Traditional Chinese Herbal Therapy in Gastric Cancer: A Comprehensive Network Pharmacology Study of the Tiao-Yuan-Tong-Wei decoction. Pharmaceuticals 2024; 17(4): 414 doi: 10.3390/ph17040414
|
| 42 |
Min Hee Yang, Seung Ho Baek, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Kwang Seok Ahn. Identification of protocatechuic acid as a novel blocker of epithelial‐to‐mesenchymal transition in lung tumor cells. Phytotherapy Research 2021; 35(4): 1953 doi: 10.1002/ptr.6938
|
| 43 |
Alessandro Agnarelli, Viviana Vella, Mark Samuels, Panagiotis Papanastasopoulos, Georgios Giamas. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022; 14(18): 4378 doi: 10.3390/cancers14184378
|
| 44 |
Elena Paccosi, Alessio Balzerano, Luca Proietti-De-Santis. Interfering with the Ubiquitin-Mediated Regulation of Akt as a Strategy for Cancer Treatment. International Journal of Molecular Sciences 2023; 24(3): 2809 doi: 10.3390/ijms24032809
|
| 45 |
Yong Xia, Zhihao Liu, Yong Huang, Xiaojun Huang, Mengya Liao, Yiwen Zhang, Xuelei Ma. A validated chiral LC method for the enantiomeric separation of AT13148 on polysaccharide-based chiral stationary phase. Journal of the Iranian Chemical Society 2018; 15(3): 711 doi: 10.1007/s13738-017-1270-2
|
| 46 |
Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells. Biotechnology Reports 2020; 25: e00438 doi: 10.1016/j.btre.2020.e00438
|
| 47 |
Yaashini Rajasegaran, Adam Azlan, Aliaa Arina Rosli, Mot Yee Yik, Khor Kang Zi, Narazah Mohd Yusoff, Emmanuel Jairaj Moses. Footprints of microRNAs in Cancer Biology. Biomedicines 2021; 9(10): 1494 doi: 10.3390/biomedicines9101494
|
| 48 |
Jeong-Hyeon Ko, Gautam Sethi, Jae-Young Um, Muthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, Anupam Bishayee, Kwang Seok Ahn. The Role of Resveratrol in Cancer Therapy. International Journal of Molecular Sciences 2017; 18(12): 2589 doi: 10.3390/ijms18122589
|
| 49 |
Honglei Wang, Yongjie Zhao, Lei Cao, Judong Zhang, Yu Wang, Min Xu. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling. Journal of Cellular Biochemistry 2019; 120(3): 3447 doi: 10.1002/jcb.27618
|
| 50 |
Mitsuro Kanda, Dai Shimizu, Koichi Sawaki, Shunsuke Nakamura, Shinichi Umeda, Takashi Miwa, Haruyoshi Tanaka, Chie Tanaka, Masamichi Hayashi, Yohei Iguchi, Suguru Yamada, Masahisa Katsuno, Yasuhiro Kodera. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01251-0
|
| 51 |
Shuwen Jiang, Xiangkun Li, Weifang Xue, Sumei Xia, Jian Wang, Yang Sai, Guangxiu Dai, Weiguo Su. Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignancies. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1392209
|
| 52 |
Masahiro Sasahara, Mitsuro Kanda, Chie Tanaka, Dai Shimizu, Shinichi Umeda, Hideki Takami, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth viaBCL‐2‐mediated intrinsic apoptosis. International Journal of Cancer 2024; 154(7): 1272 doi: 10.1002/ijc.34831
|
| 53 |
Atena Soleimani, Farzad Rahmani, Gordon A. Ferns, Mikhail Ryzhikov, Amir Avan, Seyed Mahdi Hassanian. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer. Current Pharmaceutical Design 2019; 24(39): 4605 doi: 10.2174/1381612825666190110151957
|
| 54 |
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Mahshad Kalantari, Reza Mohammadinejad, Tahereh Javaheri, Gautam Sethi. Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance. International Journal of Molecular Sciences 2020; 21(11): 4002 doi: 10.3390/ijms21114002
|
| 55 |
Asal Jalal Abadi, Ali Zarrabi, Mohammad Hossein Gholami, Sepideh Mirzaei, Farid Hashemi, Amirhossein Zabolian, Maliheh Entezari, Kiavash Hushmandi, Milad Ashrafizadeh, Haroon Khan, Alan Prem Kumar. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules 2021; 11(2): 304 doi: 10.3390/biom11020304
|
| 56 |
So-Hee Han, Jae-Han Lee, Joong-Seok Woo, Gi-Hwan Jung, Soo-Hyun Jung, Eun-Ji Han, Bumseok Kim, Sung Dae Cho, Jeong Seok Nam, Jeong Hwan Che, Ji-Youn Jung. Myricetin induces apoptosis and autophagy in human gastric cancer cells through inhibition of the PI3K/Akt/mTOR pathway. Heliyon 2022; 8(5): e09309 doi: 10.1016/j.heliyon.2022.e09309
|
| 57 |
Chie Ito, Satoshi S. Nishizuka, Kazuyuki Ishida, Noriyuki Uesugi, Tamotsu Sugai, Gen Tamura, Keisuke Koeda, Akira Sasaki. Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer. Journal of Surgical Research 2017; 212: 195 doi: 10.1016/j.jss.2017.01.018
|
| 58 |
Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu. New therapeutic options opened by the molecular classification of gastric cancer. World Journal of Gastroenterology 2018; 24(18): 1942-1961 doi: 10.3748/wjg.v24.i18.1942
|
| 59 |
Bethsebie Lalduhsaki Sailo, Kishore Banik, Sosmitha Girisa, Devivasha Bordoloi, Lu Fan, Clarissa Esmeralda Halim, Hong Wang, Alan Prem Kumar, Dali Zheng, Xinliang Mao, Gautam Sethi, Ajaikumar Bahulayan Kunnumakkara. FBXW7 in Cancer: What Has Been Unraveled Thus Far?. Cancers 2019; 11(2): 246 doi: 10.3390/cancers11020246
|
| 60 |
Yuqin Li, Xiaolan Lu, Peiying Tian, Kai Wang, Jianping Shi. Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03225-1
|
| 61 |
Man You, Junmin Fu, Xingzhi Lv, Lan Wang, Hongwei Wang, Ruifang Li. Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling. Oncology Reports 2023; 50(1) doi: 10.3892/or.2023.8573
|
| 62 |
Muhammad Abbas, Alessia Faggian, Dahiru Nasiru Sintali, Ghulam Jilany Khan, Shagufta Naeem, Meiqi Shi, Chen Dingding. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018; 103: 1688 doi: 10.1016/j.biopha.2018.04.178
|
| 63 |
Xinjie Yao, Dongyan Liu, Linyan Zhou, Ying Xie, Yan Li. FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway. Biochemical and Biophysical Research Communications 2020; 521(4): 1003 doi: 10.1016/j.bbrc.2019.11.029
|
| 64 |
Xiaohui Su, Jianjun Zhang, Wei Yang, Yanqing Liu, Yang Liu, Zexing Shan, Wentao Wang. Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00027
|
| 65 |
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma. Biomolecules 2019; 9(10): 550 doi: 10.3390/biom9100550
|
| 66 |
Jiahui Xu, Deying Liu, Huilin Niu, Guifang Zhu, Yangwei Xu, Danli Ye, Jian Li, Qingling Zhang. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. Journal of Experimental & Clinical Cancer Research 2017; 36(1) doi: 10.1186/s13046-016-0487-8
|
| 67 |
Milad Ashrafizadeh, Masoud Najafi, Hui Li Ang, Ebrahim Rahmani Moghadam, Mahmood Khaksary Mahabady, Amirhossein Zabolian, Leila Jafaripour, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hossein Saleki, Ali Zarrabi, Alan Prem Kumar. PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines 2020; 8(8): 264 doi: 10.3390/biomedicines8080264
|
| 68 |
Yufei Han, Ye Tian, Ruxin Wang, Siyu Fu, Jia Jiang, Jiawen Dong, Mingze Qin, Yunlei Hou, Yanfang Zhao. Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition. Bioorganic Chemistry 2020; 104: 104197 doi: 10.1016/j.bioorg.2020.104197
|
| 69 |
Mengjiao Han, Dongjun Dai, Neelum Aziz Yousafzai, Faliang Wang, Hanying Wang, Qiying Zhou, Haiqi Lu, Wenxia Xu, Lifeng Feng, Hongchuan Jin, Xian Wang. CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer. Oncotarget 2017; 8(61): 103557 doi: 10.18632/oncotarget.21581
|
| 70 |
Ou Li, Cheng Zhao, Jian Zhang, Feng-Nan Li, Zi-Yi Yang, Shi-Lei Liu, Chen Cai, Zi-Yao Jia, Wei Gong, Yi-Jun Shu, Ping Dong. UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-00916-7
|
| 71 |
Jeong‐Hyeon Ko, Jae‐Young Um, Seok‐Geun Lee, Woong Mo Yang, Gautam Sethi, Kwang Seok Ahn. Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells. Journal of Cellular Physiology 2019; 234(10): 18249 doi: 10.1002/jcp.28456
|
| 72 |
Irum Naz, Shanaya Ramchandani, Muhammad Rashid Khan, Min Hee Yang, Kwang Seok Ahn. Anticancer Potential of Raddeanin A, a Natural Triterpenoid Isolated from Anemone raddeana Regel. Molecules 2020; 25(5): 1035 doi: 10.3390/molecules25051035
|
| 73 |
Jeong-Hyeon Ko, Seok-Geun Lee, Woong Yang, Jae-Young Um, Gautam Sethi, Srishti Mishra, Muthu Shanmugam, Kwang Ahn. The Application of Embelin for Cancer Prevention and Therapy. Molecules 2018; 23(3): 621 doi: 10.3390/molecules23030621
|
| 74 |
Fengliang Wang, Jun Li, Rong Li, Guohua Pan, Mingxia Bai, Qiang Huang. Angelicin inhibits liver cancer growth in vitro and in vivo. Molecular Medicine Reports 2017; 16(4): 5441 doi: 10.3892/mmr.2017.7219
|
| 75 |
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, Ali Zarrabi, Michael R. Hamblin, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Kiavash Hushmandi, Alan Prem Kumar, Navid Rabiee, Milad Ashrafizadeh, Saeed Samarghandian. Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?. International Journal of Biological Macromolecules 2022; 206: 435 doi: 10.1016/j.ijbiomac.2022.02.094
|
| 76 |
Devivasha Bordoloi, Kishore Banik, Rajesh Vikkurthi, Krishan Kumar Thakur, Ganesan Padmavathi, Bethsebie Lalduhsaki Sailo, Sosmitha Girisa, Arunachalam Chinnathambi, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Constanze Buhrmann, Mehdi Shakibaei, Ajaikumar B. Kunnumakkara. Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis. Life Sciences 2020; 262: 118475 doi: 10.1016/j.lfs.2020.118475
|
| 77 |
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe-Sheng Chen, Yulong He. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01190-w
|
| 78 |
Lyla J Stanland, Micah A Luftig. Molecular Features and Translational Outlook for Epstein–Barr virus-associated Gastric Cancer. Future Virology 2018; 13(11): 803 doi: 10.2217/fvl-2018-0071
|
| 79 |
Diba Borzabadi Farahani, Hassan Akrami, Behrouz Moradi, Kiumars Mehdizadeh, Mohammad Reza Fattahi. The Effect of hsa-miR-451b Knockdown on Biological Functions of Gastric Cancer Stem-Like Cells. Biochemical Genetics 2021; 59(5): 1203 doi: 10.1007/s10528-021-10057-8
|
| 80 |
Jiayu Chen, Yanrong Hao, Jiaxin Chen, Li Huang, Wen Ao, Jiao Yang, Lei Li, Junping Heng, Zhaohon Chen, Wuqing Liang, Xin Hao, Weiwei Gao. Colony stimulating factor‑1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6‑10B cell line via the phosphoinositide 3‑kinase/Akt pathway. Oncology Letters 2018; doi: 10.3892/ol.2018.8750
|
| 81 |
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Hossein Gholami, Ali Zarrabi, Farid Hashemi, Kiavash Hushmandi, Mehrdad Hashemi, Noushin Nabavi, Francesco Crea, Jun Ren, Daniel J. Klionsky, Alan Prem Kumar, Yuzhuo Wang. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02293-6
|
| 82 |
Sadegh Fattahi, Monireh Golpour, Fatemeh Amjadi-Moheb, Marzieh Sharifi-Pasandi, Parastesh Khodadadi, Maryam Pilehchian-Langroudi, Gholam Hossein Ashrafi, Haleh Akhavan-Niaki. DNA Methyltransferases and Gastric Cancer: Insight Into Targeted Therapy. Epigenomics 2018; 10(11): 1477 doi: 10.2217/epi-2018-0096
|
| 83 |
Meng-Yao Sun, Jian Sun, Jie Tao, Yu-Xia Yuan, Zhen-Hua Ni, Qing-Feng Tang, Siyaram Pandey. Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer through ROCK/PTEN/PI3K Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/4278568
|
| 84 |
Milan Jovanović, Katarina Nikolić, Žarko Gagić, Danica Agbaba. Molecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agents. Arhiv za farmaciju 2018; 68(4): 860 doi: 10.5937/ArhFarm1804860J
|
| 85 |
Cristina Cuesta, Cristina Arévalo-Alameda, Esther Castellano. The Importance of Being PI3K in the RAS Signaling Network. Genes 2021; 12(7): 1094 doi: 10.3390/genes12071094
|
| 86 |
Kishore Banik, Abhishek Manoj Ranaware, Vishwas Deshpande, Savita Pravin Nalawade, Ganesan Padmavathi, Devivasha Bordoloi, Bethsebie Lalduhsaki Sailo, Muthu K. Shanmugam, Lu Fan, Frank Arfuso, Gautam Sethi, Ajaikumar B. Kunnumakkara. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019; 144: 192 doi: 10.1016/j.phrs.2019.04.004
|
| 87 |
Myriam Merarchi, Young Yun Jung, Lu Fan, Gautam Sethi, Kwang Seok Ahn. A Brief Overview of the Antitumoral Actions of Leelamine. Biomedicines 2019; 7(3): 53 doi: 10.3390/biomedicines7030053
|
| 88 |
Weihai Shi, Yue Fu, Zidan Zhao, Guangyao Wang, Ancheng Qin, Jing Ye, Liming Tang, Yong Jiang. Micro RNA-365-3p as a Tumor Suppressor in Gastric Cancer: Inhibition of NUCKS1-Mediated PI3K/AKT Signaling and Anti-Tumor Effects. Science of Advanced Materials 2023; 15(4): 494 doi: 10.1166/sam.2023.4456
|
| 89 |
Manjula Vinayak. Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs. Nutrition and Cancer 2018; 70(8): 1199 doi: 10.1080/01635581.2018.1539187
|
| 90 |
R D Kim, S R Alberts, C Peña, I Genvresse, A Ajavon-Hartmann, C Xia, A Kelly, J E Grilley-Olson. Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer. British Journal of Cancer 2018; 118(4): 462 doi: 10.1038/bjc.2017.428
|
| 91 |
Hye Hyeon Lee, Jin-Woo Jeong, Yung Hyun Choi. Inhibition of PI3K/AKT Signaling Pathway Enhances Cordycepin-Induced Apoptosis in Human Gastric Cancer Cells. Journal of the Korean Society of Food Science and Nutrition 2016; 45(6): 835 doi: 10.3746/jkfn.2016.45.6.835
|
| 92 |
Guya Diletta Marconi, Simone Carradori, Alessia Ricci, Paolo Guglielmi, Amelia Cataldi, Susi Zara. Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment. Molecules 2019; 24(21): 3948 doi: 10.3390/molecules24213948
|
| 93 |
Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, Farid Hashemi, Kiavash Hushmandi, Fardin Hashemi, Ebrahim Rahmani Moghadam, Reza Mohammadinejad, Masoud Najafi, Manoj Garg. Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines 2020; 8(5): 110 doi: 10.3390/biomedicines8050110
|
| 94 |
Iman W Achkar, Fatima Mraiche, Ramzi M Mohammad, Shahab Uddin. Anticancer Potential of Sanguinarine for Various Human Malignancies. Future Medicinal Chemistry 2017; 9(9): 933 doi: 10.4155/fmc-2017-0041
|
| 95 |
Lian Liu, Kwang Seok Ahn, Muthu K Shanmugam, Hong Wang, Hongyuan Shen, Frank Arfuso, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Yung Chang, Gautam Sethi, Feng Ru Tang. Oleuropein induces apoptosis via abrogating NF‐κB activation cascade in estrogen receptor–negative breast cancer cells. Journal of Cellular Biochemistry 2019; 120(3): 4504 doi: 10.1002/jcb.27738
|
| 96 |
Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Mahda Delshad, Atieh Pourbagheri-Sigaroodi, Davood Bashash. Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15293 doi: 10.1007/s00432-023-05277-x
|
| 97 |
Changchun Yu, Yongjian Xiong, Dapeng Chen, Yanli Li, Bin Xu, Yuan Lin, Zeyao Tang, Chunling Jiang, Li Wang. Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats. The Korean Journal of Physiology & Pharmacology 2017; 21(1): 1 doi: 10.4196/kjpp.2017.21.1.1
|
| 98 |
Baohong Liu, Xueting Ma, Wei Ha. Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.827444
|
| 99 |
Clarissa Esmeralda Halim, Shannon Lee Xinjing, Lu Fan, Jacqueline Bailey Vitarbo, Frank Arfuso, Chay Hoon Tan, Acharan S. Narula, Alan Prem Kumar, Gautam Sethi, Kwang Seok Ahn. Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models. Pharmacological Research 2019; 147: 104327 doi: 10.1016/j.phrs.2019.104327
|
| 100 |
Myriam Mérarchi, Gautam Sethi, Lu Fan, Srishti Mishra, Frank Arfuso, Kwang Seok Ahn. Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models. Molecules 2018; 23(10): 2538 doi: 10.3390/molecules23102538
|
| 101 |
Chongchong Wang, Li Cheng. Gankyrin as a potential therapeutic target for cancer. Investigational New Drugs 2017; 35(5): 655 doi: 10.1007/s10637-017-0474-8
|
| 102 |
Noha Elkady, Amira I Aldesoky, Dina Mohamed Allam. Can β-catenin, Tenascin and Fascin be potential biomarkers for personalized therapy in Gastric carcinoma?. Journal of Immunoassay and Immunochemistry 2023; 44(5-6): 396 doi: 10.1080/15321819.2023.2251564
|
| 103 |
Zhu Zeng, Qing Zhu. Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1382183
|
| 104 |
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri-Sigaroodi, Ali Pirsalehi, Ava Safaroghli-azar, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. European Journal of Pharmacology 2021; 898: 173983 doi: 10.1016/j.ejphar.2021.173983
|
| 105 |
Dankai Zhan, Xinxin Zhang, Jiahui Li, Xiaojiao Ding, YiXuan Cui, Jianguang Jia. MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(3): 223 doi: 10.1089/cbr.2019.3031
|
| 106 |
Hai-Jun Wang, Yu Liu, Bao-Jun Zhou, Zhan-Xue Zhang, Ai-Ying Li, Ran An, Bin Yue, Li-Qiao Fan, Yong Li. Inhibitory effects of CP on the growth of human gastric adenocarcinoma BGC-823 tumours in nude mice. Journal of International Medical Research 2018; 46(5): 1756 doi: 10.1177/0300060518761505
|
| 107 |
T. Sai Chaitanya, Sharvil Narendra Patil, Sayantani Ghosh, Jayanta K. Pal, Eiji Yuba, Rajesh Kumar Gupta. Nanotherapeutics in Cancer Vaccination and Challenges. 2022; : 349 doi: 10.1016/B978-0-12-823686-4.00015-X
|
| 108 |
Jong Hyun Lee, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Omar H.M. Shair, Gautam Sethi, Kwang Seok Ahn. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Pharmacological Research 2019; 150: 104504 doi: 10.1016/j.phrs.2019.104504
|
| 109 |
Nicola Carlomagno, Paola Incollingo, Vincenzo Tammaro, Gaia Peluso, Niccolò Rupealta, Gaetano Chiacchio, Maria Laura Sandoval Sotelo, Gianluca Minieri, Antonio Pisani, Eleonora Riccio, Massimo Sabbatini, Umberto Marcello Bracale, Armando Calogero, Concetta Anna Dodaro, Michele Santangelo. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7869802
|
| 110 |
Chongyang Ma, Fafeng Cheng, Xueqian Wang, Changming Zhai, Wenchao Yue, Yajun Lian, Qingguo Wang. Erythropoietin Pathway: A Potential Target for the Treatment of Depression. International Journal of Molecular Sciences 2016; 17(5): 677 doi: 10.3390/ijms17050677
|
| 111 |
C. Ci, C. Wu, D. Lyu, X. Chang, C. He, W. Liu, L. Chen, W. Ding. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway. Clinical and Experimental Dermatology 2020; 45(2): 194 doi: 10.1111/ced.14072
|
| 112 |
Nick Baniak, Jenna-Lynn Senger, Shahid Ahmed, S. C. Kanthan, Rani Kanthan. Gastric biomarkers: a global review. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0969-3
|
| 113 |
Jeong-Hyeon Ko, Dongwoo Nam, Jae-Young Um, Sang Jung, Gautam Sethi, Kwang Ahn. Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition. Molecules 2018; 23(7): 1601 doi: 10.3390/molecules23071601
|
| 114 |
Devesh Tewari, Pooja Patni, Anusha Bishayee, Archana N. Sah, Anupam Bishayee. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Seminars in Cancer Biology 2022; 80: 1 doi: 10.1016/j.semcancer.2019.12.008
|
| 115 |
Ju‐Min Chen, Jun‐Yun Bai, Kun‐Xian Yang. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway. IUBMB Life 2018; 70(6): 491 doi: 10.1002/iub.1749
|
| 116 |
Samantha Ong, Muthu Shanmugam, Lu Fan, Sarah Fraser, Frank Arfuso, Kwang Ahn, Gautam Sethi, Anupam Bishayee. Focus on Formononetin: Anticancer Potential and Molecular Targets. Cancers 2019; 11(5): 611 doi: 10.3390/cancers11050611
|
| 117 |
Jinglei Liu, Zhen Geng, Yingying Zhang, Sulaiman Ali Alharbi, Yulong Shi. Sesquiterpenoid bilobalide inhibits gastric carcinoma cell growth and induces apoptosis both in vitro and in vivo models. Journal of Biochemical and Molecular Toxicology 2021; 35(5) doi: 10.1002/jbt.22723
|
| 118 |
Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano. Microsatellite instability in Gastric Cancer: Between lights and shadows. Cancer Treatment Reviews 2021; 95: 102175 doi: 10.1016/j.ctrv.2021.102175
|
| 119 |
Judy Nee, Mohammed Zakari, Anthony J. Lembo. Novel Therapies in IBS-D Treatment. Current Treatment Options in Gastroenterology 2015; 13(4): 432 doi: 10.1007/s11938-015-0068-5
|
| 120 |
Caixia Sun, Youmao Tao, Yongjian Gao, Yufeng Xia, Ying Liu, Gang Wang, Ye Gu. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Biomedicine & Pharmacotherapy 2018; 98: 416 doi: 10.1016/j.biopha.2017.12.088
|
| 121 |
Sun Tae Hwang, Chulwon Kim, Jong Hyun Lee, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Omar H.M. Shair, Gautam Sethi, Kwang Seok Ahn. Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine 2019; 59: 152907 doi: 10.1016/j.phymed.2019.152907
|
| 122 |
Dharambir Kashyap, Vivek Kumar Garg, Hardeep Singh Tuli, Mukerrem Betul Yerer, Katrin Sak, Anil Kumar Sharma, Manoj Kumar, Vaishali Aggarwal, Sardul Singh Sandhu. Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential. Biomolecules 2019; 9(5): 174 doi: 10.3390/biom9050174
|
| 123 |
Alessandra Raimondi, Federico Nichetti, Giorgia Peverelli, Maria Di Bartolomeo, Filippo De Braud, Filippo Pietrantonio. Genomic Markers of Resistance to Targeted Treatments in Gastric Cancer: Potential New Treatment Strategies. Pharmacogenomics 2018; 19(13): 1047 doi: 10.2217/pgs-2018-0077
|
| 124 |
Min Hee Yang, In Jin Ha, Jae-Young Um, Kwang Seok Ahn. Albendazole Exhibits Anti-Neoplastic Actions against Gastric Cancer Cells by Affecting STAT3 and STAT5 Activation by Pleiotropic Mechanism(s). Biomedicines 2021; 9(4): 362 doi: 10.3390/biomedicines9040362
|
| 125 |
Yi Xu, Jian-yong Zhu, Zhang-ming Lei, Li-jun Wan, Xiu-wen Zhu, Feng Ye, Yan-yue Tong. Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3. Journal of Physiology and Biochemistry 2017; 73(2): 157 doi: 10.1007/s13105-016-0537-x
|
| 126 |
Hong Jun Kim, Suk-young Lee, Sang Cheul Oh. The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00168
|
| 127 |
Amina I. Makandar, Mannat Jain, Eiji Yuba, Gautam Sethi, Rajesh Kumar Gupta. Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy. Vaccines 2022; 10(12): 2049 doi: 10.3390/vaccines10122049
|
| 128 |
Chulwon Kim, Jong Hyun Lee, Jeong-Hyeon Ko, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Omar H.M. Shair, Gautam Sethi, Kwang Seok Ahn. Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model. Biomolecules 2019; 9(7): 262 doi: 10.3390/biom9070262
|
| 129 |
Jiawei Cai, Yunpeng Li, Bohao Zhao, Zhiyuan Bao, Jiali Li, Shaoning Sun, Yang Chen, Xinsheng Wu. N-Acetylcysteine Alleviates D-Galactose-Induced Injury of Ovarian Granulosa Cells in Female Rabbits by Regulating the PI3K/Akt/mTOR Signaling Pathway. Antioxidants 2024; 13(4): 384 doi: 10.3390/antiox13040384
|
| 130 |
Jong Hyun Lee, Chulwon Kim, Jae-Young Um, Gautam Sethi, Kwang Seok Ahn. Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade. Cancers 2019; 11(2): 254 doi: 10.3390/cancers11020254
|
| 131 |
Liangjun Yang, Wei Liu, Zhipeng Hu, Maoyi Yang, Jiali Li, Xiangzhen Fan, Huafeng Pan. A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action of the Wei Pi Xiao Decoction for the Treatment of Gastric Precancerous Lesions. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1562707
|
| 132 |
Weiwei Zheng, Chuancheng Wu, Xiaoli Wu, Yuanhuan Cai, Baoying Liu, Chengdang Wang. Genetic variants of autophagy-related genes in the PI3K/Akt/mTOR pathway and risk of gastric cancer in the Chinese population. Gene 2021; 769: 145190 doi: 10.1016/j.gene.2020.145190
|
| 133 |
Shuo Deng, Hin Chong Leong, Arpita Datta, Vennila Gopal, Alan Prem Kumar, Celestial T. Yap. PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression. Cancers 2022; 14(7): 1652 doi: 10.3390/cancers14071652
|
| 134 |
Yanqi Qi, Jiawen Xu, Zhe Lin, Yijing Tao, Fenglei Zheng, Yujia Wang, Yameng Sun, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong. The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease. Journal of Inflammation Research 2021; : 6043 doi: 10.2147/JIR.S338763
|
| 135 |
Dan Yang, Yang He, Bo Wu, Ruxi Liu, Nan Wang, Tieting Wang, Yannan Luo, Yunda Li, Yang Liu. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Cancer Biomarkers 2020; 29(3): 399 doi: 10.3233/CBM-200133
|